Drug giant AstraZeneca teams up with Hong Kong Science Park to drive biotech, medical research growth

The latest collaboration will involve AstraZeneca and HKSTP providing services to overseas and mainland Chinese start-ups under the park’s incubation programme, connecting them with hospitals, key opinion leaders in the bay area and universities in Hong Kong.


This website uses cookies. By continuing to use this site, you accept our use of cookies.